Results 241 to 250 of about 274,076 (393)

Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma [PDF]

, 1990
Takashi Yoshida, Shinobu Nakamura, Shigeki Ohtake, Kazuhiro Okafuji, Kazumi Kobayashi, Kunio Kondo, Masatoshi Kanno, Sadaya Matano, Tamotsu Matsuda, Masanobu Kanai, Rippou Sugimoto, Makoto Ogawa, Fumimaro Takaku   +12 more
openalex   +1 more source

An update on the diagnosis and treatment of chronic idiopathic neutropenia

Current opinion in hematology, 2017
D. Dale, A. Bolyard
semanticscholar   +1 more source

The Safety of 12‐Weekly Monitoring of Neutrophil Count in Long‐Term Clozapine Patients

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Clozapine is the only truly effective treatment for refractory schizophrenia, but its use is constrained by the requirements for frequent monitoring of neutrophil counts. In the UK during the COVID‐19 pandemic, the frequency of clozapine blood monitoring was reduced in some units from 4‐weekly to 12‐weekly. We aimed to investigate
David Taylor, Siobhan Gee, Marinka Helthuis, Ebenezer Oloyede   +3 more
wiley   +1 more source

Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin\u27s lymphoma [PDF]

, 2018
Bartlett, N. L, et al,
core   +1 more source

Abnormal responses of myeloid progenitor cells to recombinant human colony-stimulating factors in congenital neutropenia [PDF]

, 1990
Miho Kobayashi, C Yumiba, Yoshihide Kawaguchi, Y. Tanaka, K. Ueda, Y Komazawa, Kosuke Okada   +6 more
openalex   +1 more source

Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes

Annals of Human Genetics, EarlyView.
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott, Videha Sharma, Jessica Keen, William Gerard Newman   +3 more
wiley   +1 more source

Impact of mRNA COVID-19 vaccination on hematological parameters in patients maintained on clozapine: A retrospective study from Qatar. [PDF]

Explor Res Clin Soc Pharm
Albahari D, Abdallah O, Alqam SMI, Mohammed MFH, Ahmed MAS, Wadoo O.   +5 more
europepmc   +1 more source

A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia [PDF]

, 1993
DC Dale, MA Bonilla, MW Davis, AM Nakanishi, WP Hammond, Joanne Kurtzberg, W Wang, Ann A. Jakubowski, Emma De Winton, Parviz Lalezari   +9 more
openalex   +1 more source

The Optimal Timing and Duration of Daily G‐CSF for the Primary Prevention of Febrile Neutropenia in Breast Cancer Patients Undergoing Adjuvant TAC Chemotherapy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
The study aimed to determine the optimal timing and duration of filgrastim administration for the primary prevention of febrile neutropenia (FN) in breast cancer patients undergoing adjuvant TAC chemotherapy. Our findings suggest that initiating daily filgrastim from Day 2 and continuing for 7 days optimizes toxicity reduction.
Zisun Kim, Sung Mo Hur, Jong Eun Lee, Sun Wook Han, Hae Il Jung, Sung Yong Kim, Jihyoun Lee, Cheol Wan Lim   +7 more
wiley   +1 more source

Fournier's gangrene in a woman with chronic neutropenia presenting at 12 weeks of pregnancy: a case report and literature review. [PDF]

Case Rep Womens Health
Neri M, Ferrari PA, Sanna E, Caocci G, Vallerino V, Nemolato S, Locci G, Madeddu C, Runfola M, Paoletti AM, Macciò A.   +10 more
europepmc   +1 more source